BiotechTube
Home/Alzamend Neuro/Stephan Jackman
SJ

Stephan Jackman

Founder/CEO

Alzamend Neuro

Therapeutic Areas

Alzheimer's DiseaseBipolar DisorderMajor Depressive DisorderPost-Traumatic Stress Disorder

Alzamend Neuro Pipeline

DrugIndicationPhase
AL001Bipolar DisorderPhase II
ALZN002Alzheimer's DiseasePreclinical

Leadership Team at Alzamend Neuro

AH
Andrew H. Woo
Board Director
LF
Lynne Fahey McGrath
Board Director
MG
Mark Gustafson
Board Director, Audit Committee Chair
JO
Jeffrey Oram
Board Director
TM
Thomas M. Wisniewski
Scientific Advisor
EM
Eric M. McDade
Scientific Advisor
TH
Terri Hunter
Technology Transfer Advisor
View full Alzamend Neuro profile